China NMPA Product Recall - Coronary balloon dilation catheter

Abbott Medical Devices Trading (Shanghai) Co., Ltd. initiated a voluntary Level I recall of specific batches of its Coronary Artery Balloon Dilatation Catheters, as documented by the National Medical Products Administration (NMPA) with Index No. JGXX-2017-10382 and published on May 8, 2017. The company proactively identified a potential issue where the balloon protective sheath might be difficult to remove. This defect could subsequently lead to operational problems, specifically affecting the balloon's ability to inflate or contract as intended during medical procedures. Although no specific inspection dates were provided, the recall demonstrates the company's compliance with medical device regulations by voluntarily addressing a significant product quality concern. The regulatory framework for this action falls under NMPA oversight for medical device safety in China. As a required action, Abbott has proceeded with a Level I recall, signifying a serious health risk. Comprehensive details regarding the affected product models, specifications, and batch numbers are contained within the official "Medical Device Recall Event Report Form" issued by the company. This action underscores the importance of stringent quality control and prompt response to potential device malfunctions to ensure patient safety.